In order to access the documents below, you will need Adobe Acrobat 5.0 or higher.

BMT CTN Protocol 0101 -- A Randomized Double-blind Trial of Fluconazole vs. Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients

BMT CTN Protocol 0102 -- A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy versus Single Autologous Stem Cell Transplant Followed by  Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients with Multiple Myeloma

BMT CTN Protocol 0201 -- A Phase III Randomized Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors

BMT CTN Protocol 0202 -- Autologous vs. Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients with Chemosensitive Follicular Non-Hodgkin’s Lymphoma Beyond First Complete Response or First Partial Response

BMT CTN Protocol 0301 -- Fludarabine-based Conditioning for Allogeneic Marrow Transplantation from HLA-compatible Unrelated Donors in Severe Aplastic Anemia

BMT CTN Protocol 0302 -- Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (Ontak), and Pentostatin in Combination with Corticosteroids

BMT CTN Protocol 0303 -- A Single Arm, Multicenter Phase II Trial of Transplants of HLA-Matched, CD34⁺ Enriched, T cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients with AML in First or Second Morphologic Complete Remission

BMT CTN Protocol 0401 -- Phase III Rituxan/BEAM vs. Bexxar/BEAM with Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

BMT CTN Protocol 0402 -- A Phase III Randomized, Multicenter Trial Comparing
Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as GVHD Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation

BMT CTN Protocol 0403 -- A Phase III, Randomized Double-Blind, Placebo Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation

BMT CTN Protocol 0501 -- Multi-center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients with Leukemia and Myelodysplasia

BMT CTN Protocol 0502 -- A Phase II Study of Allogeneic Transplant for Older Patients with AML in First Morphologic Complete Remission using a Non-myeloblative Preparative Regimen

BMT CTN Protocol 0601 -- Unrelated Donor Hematopoietic Cell Transplantation for Children with Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen / The SCURT Study

BMT CTN Protocol 0603 -- A Multi-Center, Phase II Trial of Nonmyeloablative Conditioning (NST) and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients with Hematologic Malignancies

BMT CTN Protocol 0604 -- A Multi-Center, Phase II Trial of Non-Myeloablative Conditioning (NST) and Transplantation of Umbilical Cord Blood (UCB) from Unrelated Donors in Patients with Hematologic Malignancies

BMT CTN Protocol 0701 -- Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin’s Lymphoma Beyond First Complete Response

BMT CTN Protocol 0703/SWOG 0410 -- A Phase II Tandem Autologous Stem Cell Transplantation for Patients with Primary progressive or Recurrent Hodgkin’s Disease (A BMT Study)

The BMT CTN is committed to including widespread transplant community participation in these trials.  However, due to the limited resources, not all requests can be accommodated for each protocol.  If your center is interested in participating, please fax the completed Affiliate Center Application to BMT CTN DCC/EMMES at 301-251-1355 (or you may complete the short form if currently participating as an affiliate center on any other BMT CTN trial) .  You will be contacted if your center is selected for participation.

Please check back.  Other protocols will be added when available.